Alcohol-free red wine enhances plasma antioxidant capacity in humans.
暂无分享,去创建一个
[1] T. Koivula,et al. Relationship of alcohol consumption to changes in HDL‐subfractions , 1993, European journal of clinical investigation.
[2] L. Videla,et al. Alcohol ingestion, liver glutathione and lipoperoxidation: metabolic interrelations and pathological implications. , 1982, Life sciences.
[3] A. Ferro-Luzzi,et al. Application of a new high-performance liquid chromatographic method for measuring selected polyphenols in human plasma. , 1997, Journal of chromatography. B, Biomedical sciences and applications.
[4] A. Ferro-Luzzi,et al. Beta-carotene serum response in young and elderly females. , 1989, European Journal of Clinical Nutrition.
[5] C. Lieber,et al. Enhanced stimulatory effect of high density lipoproteins (HDL) and other agonists on vascular prostacyclin production in rats fed alcohol-containing diets. , 1989, Biochemical pharmacology.
[6] M. Katan,et al. Red wine consumption does not affect oxidizability of low-density lipoproteins in volunteers. , 1996, The American journal of clinical nutrition.
[7] A. Lavy,et al. Effect of dietary supplementation of red or white wine on human blood chemistry, hematology and coagulation: favorable effect of red wine on plasma high-density lipoprotein. , 1994, Annals of nutrition & metabolism.
[8] W. Willett,et al. Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. , 1993, The New England journal of medicine.
[9] A. Waterhouse,et al. Principal Phenolic Phytochemicals in Selected California Wines and Their Antioxidant Activity in Inhibiting Oxidation of Human Low-Density Lipoproteins , 1995 .
[10] W. Willett,et al. Mediterranean diet pyramid: a cultural model for healthy eating. , 1995, The American journal of clinical nutrition.
[11] A. Ferro-Luzzi,et al. In vivo antioxidant effect of green and black tea in man. , 1996, European journal of clinical nutrition.
[12] A. Kimball,et al. Coronary heart disease mortality and alcohol consumption in Framingham. , 1986, American journal of epidemiology.
[13] G. Ellman,et al. Tissue sulfhydryl groups. , 1959, Archives of biochemistry and biophysics.
[14] M. Taskinen,et al. Alcohol-induced changes in serum lipoproteins and in their metabolism. , 1987, American heart journal.
[15] G. Lescoat,et al. Role of flavonoids and iron chelation in antioxidant action. , 1994, Methods in enzymology.
[16] E. Rimm,et al. Prospective study of alcohol consumption and risk of coronary disease in men , 1991, The Lancet.
[17] W. E. Hillis,et al. The phenolic constituents of Prunus domestica. I.—The quantitative analysis of phenolic constituents , 1959 .
[18] T. Whitehead,et al. Effect of red wine ingestion on the antioxidant capacity of serum. , 1995, Clinical chemistry.
[19] J. Folts,et al. Administration of wine and grape juice inhibits in vivo platelet activity and thrombosis in stenosed canine coronary arteries. , 1995, Circulation.
[20] R. D. Situnayake,et al. Lipid peroxidation and hepatic antioxidants in alcoholic liver disease. , 1990, Gut.
[21] G. Ellman. TISSUE SULPHYDRYL GROUPS , 1959 .
[22] A. Lavy,et al. Consumption of red wine with meals reduces the susceptibility of human plasma and low-density lipoprotein to lipid peroxidation. , 1995, The American journal of clinical nutrition.
[23] P. Hollman,et al. Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. , 1995, The American journal of clinical nutrition.
[24] K. Kondo,et al. Inhibition of oxidation of low-density lipoprotein with red wine , 1994, The Lancet.
[25] A. Broillet,et al. The metabolism and excretion of (+)-[14C]cyanidanol-3 in man following oral administration. , 1983, Xenobiotica; the fate of foreign compounds in biological systems.
[26] W. Willett,et al. A prospective study of moderate alcohol consumption and the risk of coronary disease and stroke in women. , 1988, The New England journal of medicine.
[27] A. Ferro-Luzzi,et al. A fluorescence-based method for measuring total plasma antioxidant capability. , 1995, Free radical biology & medicine.
[28] P. Schnohr,et al. Influence of sex, age, body mass index, and smoking on alcohol intake and mortality , 1994, BMJ.
[29] B. Halliwell,et al. Inhibition of mammalian 5-lipoxygenase and cyclo-oxygenase by flavonoids and phenolic dietary additives. Relationship to antioxidant activity and to iron ion-reducing ability. , 1991, Biochemical pharmacology.
[30] P. Schnohr,et al. Mortality associated with moderate intakes of wine, beer, or spirits , 1995, BMJ.
[31] N. Das. Studies on flavonoid metabolism. Absorption and metabolism of (+)-catechin in man. , 1971, Biochemical pharmacology.
[32] E. Feskens,et al. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study , 1993, The Lancet.
[33] Y Hanasaki,et al. The correlation between active oxygens scavenging and antioxidative effects of flavonoids. , 1994, Free radical biology & medicine.
[34] A. Nègre-Salvayre,et al. Quercetin prevents the cytotoxicity of oxidized LDL on lymphoid cell lines. , 1992, Free radical biology & medicine.
[35] U. Takahama. Inhibition of lipoxygenase-dependent lipid peroxidation by quercetin: Mechanism of antioxidative function , 1985 .
[36] E. Parks,et al. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine , 1993, The Lancet.
[37] R. Cohen,et al. Change in alcohol consumption and risk of death from all causes and from ischaemic heart disease. , 1991, BMJ.
[38] S. Renaud,et al. Wine, alcohol, platelets, and the French paradox for coronary heart disease , 1992, The Lancet.
[39] A. Ferro-Luzzi,et al. Effect of Ethanol on Red Wine Tannin−Protein (BSA) Interactions , 1997 .
[40] K. Ingold,et al. Quantitative measurement of the total, peroxyl radical‐trapping antioxidant capability of human blood plasma by controlled peroxidation , 1985, FEBS letters.
[41] S. Brown,et al. The inhibition of the oxidation of low density lipoprotein by (+)-catechin, a naturally occurring flavonoid. , 1992, Biochemical pharmacology.
[42] T. Takeo,et al. Absorption of (-)-epigallocatechin gallate into the circulation system of rats. , 1995, Bioscience, biotechnology, and biochemistry.